Archive: 10/01/2017

More individual therapy for blood cancer patients

Because it is impossible to predict which acute myeloid leukaemia (AML) patients will benefit, all patients are routinely treated with chemotherapy although only some will respond to the treatment. Researchers from Goethe-University ...

page 7 from 10